UTMD (Utah Medical Products Inc) Stock Analysis - Hedge Fund Holdings
Utah Medical Products Inc (UTMD) is a publicly traded Healthcare sector company. As of May 21, 2026, UTMD trades at $64.17 with a market cap of $203.78M and a P/E ratio of 19.03. UTMD moved +0.00% today. Year to date, UTMD is +11.41%; over the trailing twelve months it is +18.35%. Its 52-week range spans $51.26 to $71.81. Rallies surfaces UTMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns UTMD stock?
Hedge funds tracked by Rallies that own UTMD include Panagora Asset. The latest tracked quarter is Sep 30, 2023. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Utah Medical Products Inc.
UTMD Key Metrics
Key financial metrics for UTMD
Metric
Value
Price
$64.17
Market Cap
$203.78M
P/E Ratio
19.03
EPS
$3.38
Dividend Yield
0.31%
52-Week High
$71.81
52-Week Low
$51.26
Volume
0
Avg Volume
0
Revenue (TTM)
$37.53M
Net Income
$10.85M
Gross Margin
57.94%
Top Hedge Funds Holding UTMD
Panagora Asset holds 2.64K shares of UTMD, changed +0.00% as of Sep 30, 2023.
RICHINS PAUL O sold 700 (~$65.43K) on May 18, 2023.
RICHINS PAUL O sold 449 (~$40.77K) on Nov 18, 2022.
RICHINS PAUL O sold 161 (~$14.49K) on Nov 17, 2022.
UTMD Analyst Consensus
UTMD analyst coverage data. Average price target: $0.00.
Common questions about UTMD
Who owns UTMD stock?
Hedge funds tracked by Rallies that own UTMD include Panagora Asset. The latest tracked quarter is Sep 30, 2023. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Utah Medical Products Inc.
Does Rallies show 13F holders for UTMD?
Yes. Rallies tracks hedge fund and 13F ownership data for UTMD, including fund names, share counts, latest tracked quarter, and position changes when available.
Is UTMD research on Rallies investment advice?
No. Rallies provides research, data, and educational context for UTMD. It does not provide personalized investment advice.